Featured Products
Our Promise to You
Guaranteed product quality, expert customer support
ONLINE INQUIRY
NRS-1
Cat.No.: CSC-C6406J
Species: Human
Morphology: other
Culture Properties: Adherent cells
- Specification
- Q & A
- Customer Review
Store in liquid nitrogen.
Emerging therapies for sarcoma cells include immune checkpoint inhibitors, gene therapies, and molecularly targeted drugs designed to inhibit specific genetic mutations prevalent in some sarcoma subtypes.
Ask a Question
Average Rating: 4.0 | 1 Scientist has reviewed this product
No contamination
Cells from Creative Bioarray are not contaminated, so we can get reliable and reproducible results.
05 June 2023
Ease of use
After sales services
Value for money
Write your own review
- You May Also Need
Description: Species: human, Caucasian male 51 years old;
Tumor: fibrosarcoma;
Derived from: metastasis to lung
Description: Species: human, Caucasian female 6 years old;
Tumor: rhabdomyosarcoma;
Derived from: TE671 (described as medulloblastoma, then confirmed as rhabdomyosarcoma, probably identical to RD).
Description: Established from a chemotherapy-resistant tumor sample obtained from the left knee of a 10-year-old boy with anaplastic osteoblastic sarcoma (Rosen grade IIB) in 1989
Description: Established from the recurrence of a dedifferentiated chondrosarcoma (grade III) of the muscle of the thigh from a 76-year-old man in 1989; tumorigenic chondrosarcomatous differentiation of xenografted tumor
Description: Established from an endometrial stromal sarcoma of the uterus of a 76-year-old Caucasian woman; cells were described as demonstrating a mainly mesenchymal phenotype with signs of epithelial characteristics within foci and an extensively multilayered growth pattern
